BeiGene, Ltd. Insider Trading for November 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BeiGene, Ltd..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BeiGene, Ltd. for November 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 22 2019 | BGNE | BeiGene, Ltd. | Glazer Donald W. | Director | Gift | G | 0.00 | 81,060 | 0 | 3,630,366 | 3.7 M to 3.6 M (-2.18 %) |
| Nov 20 2019 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Option Exercise | M | 0.50 | 325,000 | 162,500 | 3,795,000 | |
| Nov 20 2019 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 198.93 | 400 | 79,572 | 0 | 400 to 0 (-100.00 %) |
| Nov 20 2019 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 197.55 | 200 | 39,510 | 400 | 600 to 400 (-33.33 %) |
| Nov 20 2019 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 196.63 | 200 | 39,326 | 600 | 800 to 600 (-25.00 %) |
| Nov 20 2019 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 195.57 | 5,633 | 1,101,671 | 800 | 6.4 K to 800 (-87.56 %) |
| Nov 20 2019 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 194.62 | 8,156 | 1,587,311 | 6,433 | 14.6 K to 6.4 K (-55.91 %) |
| Nov 20 2019 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 193.60 | 6,944 | 1,344,334 | 14,589 | 21.5 K to 14.6 K (-32.25 %) |
| Nov 20 2019 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 192.63 | 2,311 | 445,168 | 21,533 | 23.8 K to 21.5 K (-9.69 %) |
| Nov 20 2019 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 191.80 | 1,156 | 221,724 | 23,844 | 25 K to 23.8 K (-4.62 %) |
| Nov 20 2019 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Buy | M | 6.50 | 25,000 | 162,500 | 25,000 | 0 to 25 K |
| Nov 20 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Option Exercise | M | 2.27 | 19,500 | 44,265 | 597,575 | |
| Nov 20 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 198.93 | 100 | 19,893 | 0 | 100 to 0 (-100.00 %) |
| Nov 20 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 195.82 | 95 | 18,603 | 100 | 195 to 100 (-48.72 %) |
| Nov 20 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 195.01 | 605 | 117,983 | 195 | 800 to 195 (-75.62 %) |
| Nov 20 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 193.63 | 500 | 96,813 | 800 | 1.3 K to 800 (-38.46 %) |
| Nov 20 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 192.24 | 200 | 38,448 | 1,300 | 1.5 K to 1.3 K (-13.33 %) |
| Nov 20 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Buy | M | 29.49 | 1,500 | 44,235 | 1,500 | 0 to 1.5 K |
| Nov 18 2019 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 202.05 | 395 | 79,810 | 0 | 395 to 0 (-100.00 %) |
| Nov 18 2019 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 193.57 | 2,605 | 504,242 | 395 | 3 K to 395 (-86.83 %) |
| Nov 18 2019 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 202.05 | 1,496 | 302,267 | 0 | 1.5 K to 0 (-100.00 %) |
| Nov 18 2019 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 196.87 | 100 | 19,687 | 1,496 | 1.6 K to 1.5 K (-6.27 %) |
| Nov 18 2019 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 195.86 | 300 | 58,757 | 1,596 | 1.9 K to 1.6 K (-15.82 %) |
| Nov 18 2019 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 195.14 | 1,900 | 370,774 | 1,896 | 3.8 K to 1.9 K (-50.05 %) |
| Nov 18 2019 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 194.12 | 704 | 136,662 | 3,796 | 4.5 K to 3.8 K (-15.64 %) |
| Nov 18 2019 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 193.04 | 2,200 | 424,692 | 4,500 | 6.7 K to 4.5 K (-32.84 %) |
| Nov 18 2019 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 192.19 | 2,500 | 480,482 | 6,700 | 9.2 K to 6.7 K (-27.17 %) |
| Nov 18 2019 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 191.03 | 800 | 152,826 | 9,200 | 10 K to 9.2 K (-8.00 %) |
| Nov 18 2019 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Grant | A | 0.00 | 50 | 0 | 50 | 0 to 50 |
| Nov 18 2019 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | J | 0.00 | 50 | 0 | 4,903,998 | 4.9 M to 4.9 M (0.00 %) |
| Nov 18 2019 | BGNE | BeiGene, Ltd. | Wu Xiaobin | President & GM Chin ... | Sell | S | 202.05 | 1,000 | 202,050 | 0 | 1,000 to 0 (-100.00 %) |
| Nov 06 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Option Exercise | M | 2.27 | 427,700 | 970,879 | 617,075 | |
| Nov 06 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 192.77 | 300 | 57,831 | 0 | 300 to 0 (-100.00 %) |
| Nov 06 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 191.96 | 2,854 | 547,844 | 300 | 3.2 K to 300 (-90.49 %) |
| Nov 06 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 191.01 | 12,654 | 2,417,011 | 3,154 | 15.8 K to 3.2 K (-80.05 %) |
| Nov 06 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 190.00 | 12,523 | 2,379,399 | 15,808 | 28.3 K to 15.8 K (-44.20 %) |
| Nov 06 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 189.08 | 4,569 | 863,921 | 28,331 | 32.9 K to 28.3 K (-13.89 %) |
| Nov 06 2019 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Buy | M | 29.49 | 32,900 | 970,221 | 32,900 | 0 to 32.9 K |
| Nov 06 2019 | BGNE | BeiGene, Ltd. | Chen Timothy Yung-Cheng | Director | Option Exercise | M | 3.16 | 52,000 | 164,320 | 65,988 | |
| Nov 06 2019 | BGNE | BeiGene, Ltd. | Chen Timothy Yung-Cheng | Director | Option Exercise | M | 3.16 | 52,000 | 164,320 | 117,988 | |
| Nov 06 2019 | BGNE | BeiGene, Ltd. | Chen Timothy Yung-Cheng | Director | Sell | S | 192.06 | 200 | 38,411 | 0 | 200 to 0 (-100.00 %) |
| Nov 06 2019 | BGNE | BeiGene, Ltd. | Chen Timothy Yung-Cheng | Director | Sell | S | 190.32 | 208 | 39,587 | 200 | 408 to 200 (-50.98 %) |
| Nov 06 2019 | BGNE | BeiGene, Ltd. | Chen Timothy Yung-Cheng | Director | Sell | S | 189.56 | 1,892 | 358,640 | 408 | 2.3 K to 408 (-82.26 %) |
| Nov 06 2019 | BGNE | BeiGene, Ltd. | Chen Timothy Yung-Cheng | Director | Sell | S | 188.71 | 1,500 | 283,070 | 2,300 | 3.8 K to 2.3 K (-39.47 %) |
| Nov 06 2019 | BGNE | BeiGene, Ltd. | Chen Timothy Yung-Cheng | Director | Sell | S | 187.38 | 200 | 37,476 | 3,800 | 4 K to 3.8 K (-5.00 %) |
| Nov 06 2019 | BGNE | BeiGene, Ltd. | Chen Timothy Yung-Cheng | Director | Buy | M | 41.01 | 4,000 | 164,040 | 4,000 | 0 to 4 K |
| Nov 06 2019 | BGNE | BeiGene, Ltd. | Chen Timothy Yung-Cheng | Director | Sell | S | 192.18 | 100 | 19,218 | 0 | 100 to 0 (-100.00 %) |
| Nov 06 2019 | BGNE | BeiGene, Ltd. | Chen Timothy Yung-Cheng | Director | Sell | S | 191.32 | 1,306 | 249,862 | 100 | 1.4 K to 100 (-92.89 %) |
| Nov 06 2019 | BGNE | BeiGene, Ltd. | Chen Timothy Yung-Cheng | Director | Sell | S | 190.34 | 1,394 | 265,338 | 1,406 | 2.8 K to 1.4 K (-49.79 %) |
| Nov 06 2019 | BGNE | BeiGene, Ltd. | Chen Timothy Yung-Cheng | Director | Sell | S | 189.37 | 1,200 | 227,244 | 2,800 | 4 K to 2.8 K (-30.00 %) |
| Nov 06 2019 | BGNE | BeiGene, Ltd. | Chen Timothy Yung-Cheng | Director | Buy | M | 41.01 | 4,000 | 164,040 | 4,000 | 0 to 4 K |
| Nov 05 2019 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 190.00 | 1,000 | 190,000 | 0 | 1,000 to 0 (-100.00 %) |
| Nov 05 2019 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 170.00 | 1,000 | 170,000 | 0 | 1,000 to 0 (-100.00 %) |